Clinical trial
An Open Randomized Study on the Efficacy and Safety of Hemoadsorption With Efferon CT in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
NCT06955936 is registered in ClinicalTrials.gov with Efferon JSC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Randomized Study on the Efficacy and Safety of Hemoadsorption With Efferon CT in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction
- Lead sponsor
- Efferon JSC
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- April 29, 2025
- Completion date
- July 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cardiogenic shock, myocardial infarction